// App-Quantinova.ai

TCT-389 : Prospective Evaluation of the Drug-Eluting Self-Apposing Stent for the Treatment of Unprotected Left Main Coronary Artery Disease: 2-Year Results of the TRUNC Study

Researchers

Presenter

  • Corrado Tamburino

Principal Investigators

  • Briguori Carlo

  • Gillian A. Jessurun

  • Markus Meyer-Gessner

  • Krzysztof Reczuch

  • Bernardo Cortese

  • Luc Maillard

  • Rutger L. Anthonio

  • Alessio La Manna

  • Marie-Claude Morice

  • Andreas Baumbach

  • Vi-Phong Huynh

Medical Centers

  • Augusta Krankenhaus, Dusseldorf, Germany

  • University of Catania, Catania, Italy

  • CERC, Massy, France

  • Heart Diseases Center, Medical University of Wrocław, Wroclaw, Poland

  • Mediterranea Cardiocentro, Napoli, Italy

  • Treant Zorggroep, Emmen, Netherlands

  • Barts Heart Centre, London, United Kingdom

  • GCS ES Axium Rambot, Aix en Provence, France

  • Division of Cardiology, Policlinico-Vittorio Emanuele Hospital, University of Catania, Catania, Italy

  • STENTYS (Inc. MINVASYS), Gennevilliers, France

  • San Carlo Clinic, Milano, Milan, Italy

Locations

  • Germany

  • France

  • Poland

  • Italy

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Left main disease

  • Coronary Artery Disease

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved